Biopsy avoidance strategy in adult coeliac disease by Marks, L. et al.
This is a repository copy of Biopsy avoidance strategy in adult coeliac disease.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/134935/
Version: Accepted Version
Proceedings Paper:
Marks, L., Lau, M., Kurien, M. orcid.org/0000-0002-4227-9500 et al. (9 more authors) 
(2018) Biopsy avoidance strategy in adult coeliac disease. In: Gut. BSG 2018, 04-07 Jun 
2018, Liverpool, UK. BMJ Publishing Group , A140-A141. 
https://doi.org/10.1136/gutjnl-2018-BSGAbstracts.280
© 2018 The Authors. This is an author produced version of a paper subsequently 
published in Gut. Uploaded in accordance with the publisher's self-archiving policy.
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Biopsy avoidance strategy in adult Coeliac Disease 
 
Introduction:  
Currently, the diagnosis of Coeliac disease (CD) requires the presence of villous 
atrophy (VA) on duodenal biopsy. However, biopsies are expensive, invasive and 
poorly tolerated by many patients. Paediatric ESPGHAN guidelines support a 
diagnosis of CD when immunoglobulin-A anti-tissue transglutaminase (IgA tTG) 
antibody titres are greater than 10 times the upper limit of normal (ULN) and 
combined with supportive criteria. This study examines whether serological testing 
alone could be sufficient for diagnosis in adult patients, thus avoiding the need for 
gastroscopy and duodenal biopsies. 
 
Aims and Methods:  
The aim of this study was to assess whether an IgA tTG value of greater than 10 
times the ULN could produce a 100% positive predictive value (PPV) for the 
detection of VA. We performed a prospective analysis of CD patients diagnosed in a 
University hospital. Symptoms of CD, VA on biopsy, IgA-endomysial (IgA-EMA) 
antibodies, tTG and Human Leukocyte Antigen (HLA) genotype were used for 
analysis. We then compared the TTG antibody level against small bowel histology. 
 
Results:  
443 CD patients (66.8% female, median age 41 years, range 15-84 years) were 
diagnosed between 2008 and 2016. 56.9% (n=252, 95% CI= 52.12-61.53) had a tTG 
value of greater than 10 times the ULN, and 100% of these patients had VA on 
biopsy. 292 fulfilled ESPGHAN guidelines for features of malabsorption 
(diarrhoea=157, weight loss=45 and anaemia=190). Of these symptomatic patients, 
70.4% (n=179, 95% CI= 64.86-76.08) had a tTG value 10 x ULN. The proportion 
reaching the 10 x tTG threshold was 55.4% (n=87, 95% CI=47.64-63.19) for 
diarrhoea, 60.0% (n=27, 95% CI=45.69-74.31) for weight loss, and 74.2% (n=141, 
95% CI=67.99-80.43) for anaemia. Of the 151 patients who did not experience 
malabsorptive features, 49.0% met the 10 x ULN tTG level (n=74, 95%CI= 41.03-
56.98). The sensitivity of tTG antibodies and EMA antibodies for predicting VA was 
93.2% (95% CI=90.89-95.57) and 90.7% respectively (95% CI=88.05-93.44). 
Combined tTG and EMA was 98.6% (95% CI=97.67-99.72). All patients had 
compatible HLA typing, thereby failing to add any further diagnostic value. 
 
Conclusions:  
An IgA tTG level of >10 times the ULN had a PPV of 100% for detecting VA. Using 
this threshold, 56.9% of patients would have been correctly diagnosed with CD and 
avoided duodenal biopsy. Symptoms and HLA typing did not add any supportive 
information. This study provides evidence that a biopsy avoidance strategy may be 
implemented into adult gastroenterological practice.  
